quote:
Kerel leer begrijpend lezen er staat:
quote:
...the nutrient solution for the vaccine consists of cancerous cells from animals and "we do not know if there could be an allergic reaction".
Oke zou kunnen een allergische reactie op de cellen als deze nog aanwezig zijn in de emulsie. Zijn bij kippenei vaccinaties wel gevallen van beschreven.
quote:
But more importantly, some people fear that the risk of cancer could be increased by injecting the cells.
Sommige mensen zijn bang dat het risico op kanker verhoogt is door deze cellen te gebruiken. Er staat dus helemaal niet dat het vaccin dat zou veroorzaken. Daar komt nog bij dat als er cellijn resten of cellen inzitten deze meteen opgeruimt worden door je immuunsysteem omdat dit (in tegenstelling tot normale kanker) herkent wordt als lichaamsvreemd. Je zou echt zwaar imuungecompromiteerd moeten zijn willen die cellen zich kunnen enten en uitgroeien tot een tumor. En als je zo immuungecompromiteerd bent heeft een vaccin ook al geen enkele zin.
O en dat lijstje

ik kan zo ook een lijstje maken met overleden schrijvers of muzikanten waarin je een politiek motief kunt
zien. Dat is het hem nou juist een mens probeerd altijd verbanden te vinden. Zelfs als deze er niet zijn, dan zal onze geest er toch wat van maken. En voor jezelf is het ook overtuigend.
Stel ik zie een bruine kip bruine worpjes en zaadjes eten. En ik heb verder nooit kippen gezien. En weet niets van biochemie. Dan zou ik de hypothese kunnen bedenken. "Die kip is bruim omdat hij bruin voer eet.

" Die aanname is op basis van mijn ervaring op dat moment heel aannemelijk. En als ik nooit een witte of rode kip met precies hetzelfde dieet te zien krijg zal dit voor mijn gevoel ook waar zijn.
Er is geen causaal verband tussen vaccinatie en Autisme
quote:
OBJECTIVE: After concerns about the possible toxicity of thimerosal-containing vaccines in the United States, this study was designed to investigate whether there is a relationship between the amount of thimerosal that an infant receives via diphtheria-tetanus-whole-cell pertussis (DTP) or diphtheria-tetanus (DT) vaccination at a young age and subsequent neurodevelopmental disorders. METHODS: A retrospective cohort study was performed using 109 863 children who were born from 1988 to 1997 and were registered in general practices in the United Kingdom that contributed to a research database. The disorders investigated were general developmental disorders, language or speech delay, tics, attention-deficit disorder, autism, unspecified developmental delays, behavior problems, encopresis, and enuresis. Exposure was defined according to the number of DTP/DT doses received by 3 and 4 months of age and also the cumulative age-specific DTP/DT exposure by 6 months. Each DTP/DT dose of vaccine contains 50 microg of thimerosal (25 microg of ethyl mercury). Hazard ratios (HRs) for the disorders were calculated per dose of DTP/DT vaccine or per unit of cumulative DTP/DT exposure. RESULTS: Only in 1 analysis for tics was there some evidence of a higher risk with increasing doses (Cox's HR: 1.50 per dose at 4 months; 95% confidence interval [CI]: 1.02-2.20). Statistically significant negative associations with increasing doses at 4 months were found for general developmental disorders (HR: 0.87; 95% CI: 0.81-0.93), unspecified developmental delay (HR: 0.80; 95% CI: 0.69-0.92), and attention-deficit disorder (HR: 0.79; 95% CI: 0.64-0.98). For the other disorders, there was no evidence of an association with thimerosal exposure. CONCLUSIONS: With the possible exception of tics, there was no evidence that thimerosal exposure via DTP/DT vaccines causes neurodevelopmental disorders.
Bron: http://pediatrics.aappublications.org/cgi/content/full/118/4/1664
Hier is gekeken of de leeftijd van de kinderen misschien van invloed was. Dit bleek niks uit te maken. Zowel de kinderen met als zonder waren op dezelfde leeftijd gevaccineerd.
quote:
OBJECTIVE: To compare ages at first measles-mumps-rubella (MMR) vaccination between children with autism and children who did not have autism in the total population and in selected subgroups, including children with regression in development. METHODS: A case-control study was conducted in metropolitan Atlanta. Case children (N = 624) were identified from multiple sources and matched to control children (N = 1824) on age, gender, and school. Vaccination data were abstracted from immunization forms required for school entry. Records of children who were born in Georgia were linked to Georgia birth certificates for information on maternal and birth factors. Conditional logistic regression was used to estimate odds ratios (ORs). RESULTS: The overall distribution of ages at MMR vaccination among children with autism was similar to that of matched control children; most case (70.5%) and control children (67.5%) were vaccinated between 12 and 17 months of age. Similar proportions of case and control children had been vaccinated before 18 or before 24 months. No significant associations for either of these age cutoffs were found for specific case subgroups, including those with evidence of developmental regression. More case (93.4%) than control children (90.6%) were vaccinated before 36 months (OR: 1.49; 95% confidence interval: 1.04-2.14 in the total sample; OR: 1.23; 95% confidence interval: 0.64-2.36 in the birth certificate sample). This association was strongest in the 3- to 5-year age group. CONCLUSIONS: Similar proportions of case and control children were vaccinated by the recommended age or shortly after (ie, before 18 months) and before the age by which atypical development is usually recognized in children with autism (ie, 24 months). Vaccination before 36 months was more common among case children than control children, especially among children 3 to 5 years of age, likely reflecting immunization requirements for enrollment in early intervention programs.
Bron: http://pediatrics.aappublications.org/cgi/content/full/113/2/259
En nog een onderzoek uit Denemarken. Met een groot cohort, waardoor het een grotere betrouwbaarheid heeft
quote:
CONTEXT: Mercuric compounds are nephrotoxic and neurotoxic at high doses. Thimerosal, a preservative used widely in vaccine formulations, contains ethylmercury. Thus it has been suggested that childhood vaccination with thimerosal-containing vaccine could be causally related to neurodevelopmental disorders such as autism. OBJECTIVE: To determine whether vaccination with a thimerosal-containing vaccine is associated with development of autism. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study of all children born in Denmark from January 1, 1990, until December 31, 1996 (N = 467 450) comparing children vaccinated with a thimerosal-containing vaccine with children vaccinated with a thimerosal-free formulation of the same vaccine. MAIN OUTCOME MEASURES: Rate ratio (RR) for autism and other autistic-spectrum disorders, including trend with dose of ethylmercury. RESULTS: During 2 986 654 person-years, we identified 440 autism cases and 787 cases of other autistic-spectrum disorders. The risk of autism and other autistic-spectrum disorders did not differ significantly between children vaccinated with thimerosal-containing vaccine and children vaccinated with thimerosal-free vaccine (RR, 0.85 [95% confidence interval [CI], 0.60-1.20] for autism; RR, 1.12 [95% CI, 0.88-1.43] for other autistic-spectrum disorders). Furthermore, we found no evidence of a dose-response association (increase in RR per 25 microg of ethylmercury, 0.98 [95% CI, 0.90-1.06] for autism and 1.03 [95% CI, 0.98-1.09] for other autistic-spectrum disorders). CONCLUSION: The results do not support a causal relationship between childhood vaccination with thimerosal-containing vaccines and development of autistic-spectrum disorders.
Bron: http://jama.ama-assn.org/cgi/content/full/290/13/1763
Oftewel geen significant causaal verband.
[ Bericht 17% gewijzigd door switchboy op 06-10-2009 22:09:15 ]